510(k) Report

510(k) · Cleared

Recalled · Class II · 2014

Retcam 3 Opthalmic Imaging System

K102859510(k) TraditionalCleared Apr 20, 2011202-day reviewClass II21 CFR 886.1120Recalls 2

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Clarity Medical Systems · HKI Camera, Ophthalmic, Ac-Powered

Cleared on Apr 20, 2011 as substantially equivalent to K090326 (Clarity Medical Systems, 2009) and 1 other predicate after a 202-day review. Its family tree reaches back 3 generations to 2008. 4 later devices descend from it. It has been recalled 2 times.

Decided
Apr 20, 2011
Review
202 days
Class
Class II
Product code
HKI
Recalls
2
Predicates
2

Its longest line of descent runs back 3 generations to K081858 (2008). 4 later devices descend from it, 2 citing it directly.

  1. Root · 3 generations backK081858 Retcam 3 Ophthalmic Imaging SystemClarity Medical Systems · 2008 · Recalled
  2. 2 generations backK083771 Retcam Portable Ophthalmic Imaging System, Model RCPClarity Medical Systems · 2009
  3. 1 generation backK090326 Ret Cam II, Retcam 3 and Retcam Shuttle and Portable Ophthalmic…Clarity Medical Systems · 2009 · Recalled
  4. This deviceK102859 Retcam 3 Opthalmic Imaging SystemClarity Medical Systems · 2011
  5. Descendant · cites it directly · 3 of its ownK170527 Phoenix Clinical ICONPhoenix Technology Group, Inc. Dba Phoenix Clinical · 2017
  6. Descendant · cites it directly · 1 of its ownK183059 3nethra neoForus Health Pvt.Ltd · 2018
  7. Descendant · 2 generations on · 0 of its ownK243600 3nethra neo HD FA; 3nethra neo HDForus Health Pvt.Ltd · 2025
  8. Descendant · 2 generations on · 0 of its ownK223575 Phoenix ICON, Phoenix ICON GONeolight, LLC · 2023

Most influential descendants

Showing 4 of 4 · See all
  • K170527Phoenix Clinical ICONPhoenix Technology Group, Inc. Dba Phoenix Clinical · 2017 · cites it directly3descendants
  • K1830593nethra neoForus Health Pvt.Ltd · 2018 · cites it directly1descendant
  • K2436003nethra neo HD FA; 3nethra neo HDForus Health Pvt.Ltd · 2025 · 2 generations on0descendants
  • K223575Phoenix ICON, Phoenix ICON GONeolight, LLC · 2023 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K081858Retcam 3 Ophthalmic Imaging SystemClarity Medical Systems20083
−2K083771Retcam Portable Ophthalmic Imaging System, Model RCPClarity Medical Systems2009—
−1K090326Ret Cam II, Retcam 3 and Retcam Shuttle and Portable Ophthalmic Imaging SystemsClarity Medical Systems20092
0 (this device)K102859Retcam 3 Opthalmic Imaging SystemClarity Medical Systems2011—
+1K170527Phoenix Clinical ICONPhoenix Technology Group, Inc. Dba Phoenix Clinical2017—
+1K1830593nethra neoForus Health Pvt.Ltd2018—
+2K2436003nethra neo HD FA; 3nethra neo HDForus Health Pvt.Ltd2025—
+2K223575Phoenix ICON, Phoenix ICON GONeolight, LLC2023—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201710
201810
202310
202510
FIG. 1 — Lineage of K102859, 2008–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in HKI? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new HKI device

  1. #1 K253176 TearViewscore 12.7 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K090326Ret Cam II, Retcam 3 and Retcam Shuttle and Portable Ophthalmic Imaging Systems
Summary page 1
…Code(s): HKI Equivalent Predicate RetCam. 3 Ophthalmic Imaging System, K(090326, K081 858 Device: Ret~am 11 Ophthalmic Imaging System, K090326, K08 1858 Device Description: The RetCamn 3 Ophthalmic Imaging System utilizes a digital camera in a handpiece with…
Clarity Medical Systems20092
*K081858Retcam 3 Ophthalmic Imaging System
Summary page 1
…Class 11 Classification Panel: Ophthalmology Product Code(s): HKI Equivalent Predicate RetCam. 3 Ophthalmic Imaging System, K(090326, K081 858 Device: Ret~am 11 Ophthalmic Imaging System, K090326, K08 1858 Device Description: The RetCamn 3 Op…
Clarity Medical Systems20083

Also cleared against K090326: 1 other device →

What descends from it? (4)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K170527Phoenix Clinical ICONPhoenix Technology Group, Inc. Dba Phoenix Clinical20173
K1830593nethra neoForus Health Pvt.Ltd20181

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jan 24, 2014Class IIZ-1154-2014Software Manufacturing/Software DeploymentSoftware anomaly for RetCam 3, RetCam Shuttle and RetCam Portable with software versions 6.0.x, 6.1. x and 6.2x where the patients age is calculated incorrectly.
Feb 2, 2012Not classifiedZ-1099-2012Software designStill images extracted from video recordings may be mislabeled as to right and left eye.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 3 years and passes through 1 company; a new generation was cleared every 10 months on median.
  • 2 of the 3 ancestors have a recall of any class.
  • Of its descendants, K170527 (Phoenix Technology Group, Inc. Dba Phoenix Clinical, 2017) has gone furthest, with 3 descendants of its own.
  • 1 other device also cites its predicate K090326.

How does its category compare?

All HKI devices

HKI Camera, Ophthalmic, Ac-Powered: FDA decisions, review times, recalls and adverse event reports over 20 years. 2011, this device’s year, is highlighted.

FDA decisions per year · HKI

4in 2025

2007: 22008: 52009: 112010: 62011: 72012: 52013: 72014: 42016: 42017: 22018: 62019: 42020: 52021: 42022: 12023: 52024: 32025: 42026 (partial year): 2
2007high 11 (2009) · low 0 (2015)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · HKI

167in 2025

2008: 29 days median2009: 104 days median2010: 140 days median2011: 160 days median2012: 179 days median2013: 141 days median2014: 135 days median2016: 146 days median2018: 71 days median2019: 73 days median2020: 182 days median2021: 155 days median2023: 259 days median2024: 28 days median2025: 167 days median
2007high 259 (2023) · low 28 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · HKI

1in 2018

2012: 12016: 12017: 12018: 1
2007high 1 (2012) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · HKI

1in 2023

2007: 32008: 12009: 12012: 22013: 222014: 32015: 32016: 662017: 202018: 142020: 52021: 32022: 12023: 1
2007high 66 (2016) · low 0 (2010)2025

MAUDE reports naming product code HKI, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—03
200852901
20091110401
2010614000
2011716000
2012517912
20137141022
2014413503
20150—03
20164146166
20172—120
2018671114
201947300
2020518205
2021415503
20221—01
2023525901
202432800
2025416700
20262—0—

What is it indicated for?

General ophthalmic imaging including retinal, corneal, and external imaging;

Photodocumentation of pediatric ocular diseases including retinopathy of prematurity (ROP).

Screening for Type 2 pre-threshold retinopathy of prematurity (ROP) (zone 1, stage 1 or 2, without plus disease, or zone 2, stage 3, without plus disease) or treatment-requiring ROP, defined as Type 1 ROP (zone 1, any stage, with plus disease; zone 1, stage 3 without plus disease; or zone 2, stage 2 or 3, with plus disease) or threshold ROP (at least 5 contiguous or 8 non-contiguous clock hours of stage 3 in zone 1 or 2, with plus disease)* in 35-37 week postmenstrual infants.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K102859: Retcam 3 Opthalmic Imaging System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K102859

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026